BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,854 Cr | ₹-2,333 Cr | ₹13,049 Cr | ₹242 Cr | ₹2,564 Cr |
What is the latest Cash Flow from Financing Activities ratio of BIOCON ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1,854 Cr |
| Mar2024 | ₹-2,333 Cr |
| Mar2023 | ₹13,049 Cr |
| Mar2022 | ₹242 Cr |
| Mar2021 | ₹2,564 Cr |
How is Cash Flow from Financing Activities of BIOCON Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1,854 Cr | Negative | |
| Mar2024 | ₹-2,333 Cr | Negative | |
| Mar2023 | ₹13,049 Cr | 5,289.80 | |
| Mar2022 | ₹242 Cr | -90.56 | |
| Mar2021 | ₹2,564 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹66,789.2 Cr | -3.2% | 8.2% | 23.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,654.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -3.2% |
8.2% |
23.9% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses